The End of Cut, Poison & Burn: How AI is Rewriting Cancer Care With: Dr. Chadi Nabhan
In this thought-provoking episode, Dr. Chadi Nabhan joins a roundtable with Drs. Sanjay Jani, Douglas Flora, and Debra Patt to examine how AI is transforming oncology. Once dominated by the traditional “cut, poison, burn” approach, cancer care is undergoing a shift driven by precision tools, targeted therapies, and intelligent systems. Dr. Nabhan, a seasoned oncologist and prolific author, shares insights from his latest book and underscores the need for scalable education on emerging technologies. The conversation covers everything from digital pathology and drug development to patient communication and the emotional toll of missed timing in treatment. This episode offers a rich blend of clinical depth and personal reflection—an essential listen for healthcare professionals navigating cancer's new digital frontier.
Episode Contents:
About the Guest
Dr. Chadi Nabhan is a hematologist and medical oncologist with a passion for precision medicine and healthcare policy. He is an author, speaker, and host of the "Healthcare Unfiltered" podcast. Learn more about his work here: https://www.linkedin.com/in/chadi-nabhan-md-mba-facp-97a85488/.
Key Takeaways
- AI in oncology reduces diagnostic error and accelerates treatment timelines.
- Patient understanding still relies on trusted voices despite abundant information.
- Drug discovery and trial design are being revolutionized by machine learning.
Transcript Summary
Why Cancer Care Needs a Reboot
What motivated you to write about the transformation in oncology?
Dr. Nabhan and Dr. Flora both describe a sense of urgency. Dr. Nabhan emphasizes that despite an abundance of online cancer information, many patients still arrive in clinic confused. His book aims to translate oncology for laypeople. Dr. Flora adds that the current flood of data demands thoughtful curation from professionals.
From "Cut, Poison, Burn" to AI-Enabled Precision
How do current tools reshape the classic cancer care model?
The group discusses how AI augments traditional approaches with tools like digital pathology and real-time decision support. Dr. Patt highlights the need for clinical awareness of AI’s limitations to avoid bias and harm.
The Role of Trust and Communication
With so much tech, where does the human element fit?
All guests agree that communication remains central. Dr. Nabhan shares that early in his career, he mistakenly blamed patients for not understanding. Over time, he realized effective communication is the clinician's responsibility.
The Urgency of Adoption
Why is timely integration of AI critical?
Dr. Flora recalls losing patients just before new therapies became available. Speeding up trial development and FDA approval via AI is a moral imperative, not just a technical one.
Advice for the Next Generation
What should someone do if they want to shift careers or explore healthcare innovation?
Each guest advises finding purpose through passion, continuous learning, and connecting with communities already innovating in healthcare. They stress that growth and impact are always possible at any career stage.
More Topics
- Healthcare Ethics and Policy
- AI in Patient Care
- AI in the Healthcare Industry
- AI and Medical Innovation
Keep Exploring
About the Series
Leading oncology AI thought leaders Drs. Sanjay Juneja, Debra Patt, and Doug Flora bring you conversations at the intersection of medicine, data, and innovation. Each episode explores both the big picture and the breaking news in artificial intelligence and healthcare—examining how today’s technology is reshaping the practice and business of oncology.
From industry disruptors to clinical pioneers, guests share insights that bridge the gap between algorithms and the art of patient care.
To learn more about the mission and upcoming initiatives, visit tensorblack.ai and subscribe to stay ahead of the curve.